ArticleMolecular neurobiology2025
PKCγ-mediated Phosphorylation of Mtss1 Regulates the Dendritic Outgrowth and Spine Development of Cerebellar Purkinje Cells.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Protein kinase C gamma (PKCγ) is a signalling protein expressed in Purkinje cells (PCs) of the cerebellum. It is involved in regulating synapse formation and PC dendritic development through phosphorylation of target proteins that control cytoskeleton dynamics and PC dendritic morphology. Mutations in the protein kinase C gamma gene cause spinocerebellar ataxia 14 (SCA14), an autosomal dominant neurodegenerative disease leading to motor deficits and cognitive decline. The molecular targets of PKCγ and its interaction with cytoskeletal regulators are not yet well understood. Using a PKCγ mutant mouse line (PKCγ-A24E), which expresses a constitutively active PKCγ causing an SCA14-like phenotype, we identified Metastasis suppressor protein 1 (Mtss1) as a PKCγ molecular target involved in PC dendritic development. The two Mtss1 phospho-sites (S265 and S266) showed an increased phosphorylation in the cerebellum of PKCγ-A24E mice compared to wildtypes. Altering Mtss1-S265 and Mtss1-S266 with phospho-mimetic and phospho-defective mutations led to a loss of PC dendritic tree complexity in dissociated cerebellar cultures, with a developmental delay, a decreased dendritic branching, reduced spine density, and fewer synaptic processes, partially mimicking the PKCγ-A24E phenotype. Moreover, we found that these Mtss1 effects are partially regulated via the Arp2/3 complex. Our results demonstrate the importance of PKCγ-mediated phosphorylation of Mtss1 at S265 and S266 for PC dendritic outgrowth and suggest its contribution to PKCγ cytoskeleton signalling and the SCA14 phenotype.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.